WT

Warwick Tong

Amplia Therapeutics Limited | Non-Executive Director, Non-Executive Chairman
Dr Tong has more than 30 years of experience in the Pharmaceutical and Biotechnology industry. After his early career in General Medical Practice, Dr Tong has held a wide variety of roles in the pharmaceutical and biotech industry in NZ (Glaxo) Singapore (GlaxoWellcome) London (GSK), Boston (Surface Logix) and Melbourne (CTx Cancer Therapeutics CRC). His roles have included Medical Director, Regional Business Development Director (Asia Pacific), Commercial Strategy Director (International) and SVP Development (USA). Dr Tong is also a member of the Risk Committee.

Company and Roles

Company
Title
Tenure
Since
ATX
ATX
Amplia Therapeutics Limited
  • Non-Executive Director
  • Non-Executive Chairman
6yrs, 11mthMay 2018

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
ATX
ATX
Amplia Therapeutics Limited
20/12/242,355,1401,356,7591,271,739N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
ATX
ATX
Amplia Therapeutics Limited
20/12/24
Issued
695,652$0.115$79,999As advised by the company
ATX
ATX
Amplia Therapeutics Limited
20/12/24
Transfer
661,107$0.083$54,871Off-market transfer
ATX
ATX
Amplia Therapeutics Limited
20/12/24
Issued
521,739$0.083$43,304As advised by the company
ATX
ATX
Amplia Therapeutics Limited
20/12/24
Transfer
661,107$0.083$54,871Off-market transfer
ATX
ATX
Amplia Therapeutics Limited
06/09/22
Issued
750,000$0.100$75,000Issue of options